Subtitle
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Subtitle
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Proto therapy Time
March 2024
Executive summary
This is a trial protocol of FAST-02. This trial includes 10 patients with 1-3 painful bone metastases in the thorax, excluding bone metastases in the spine. Treatment will be 8 Gy in a single fraction administered at ≥ 40 Gy/s on a FLASH-enabled proton therapy system delivering a single transmission proton beam. Primary study endpoints are efficacy (pain relief) and safety. Registration: ClinicalTrials.gov NCT05524064.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
April 2024
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.
Webinar
April 25, 2024
Translating ConformalFLASH® from Research to Reality
Yohan
Godart
Michele
Kim
Jarrick
Nys
Proton Therapy Publication
January 2021
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy.
Proton Therapy Publication
September 2023
Ultra-High Dose-Rate Proton FLASH Improves Tumor Control.
Webinar
ConformalFLASH® - Overview
Swati
Girdhani
Nicolas
Denef
Proton Therapy Publication
July 2023
Proton FLASH Radiation Therapy and Immune Infiltration: Evaluation in an Orthotopic Glioma Rat Model.
Proton Therapy Publication
June 2023
The current status of FLASH particle therapy: a systematic review.
Webinar
December 2, 2022
ConformalFLASH®: treat deeper, faster, and sharper with protons
Rudi
Labarde
François
Vander Stappen
Lucian
Hotoiu
Swati
Girdhani